NCT06800105Recruiting
Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
Source: ClinicalTrials.gov · Last updated 29 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Minimal information is available regarding changes in whole-body metabolism in ovarian cancer patients, and no study has assessed whole-body lipid metabolism in this patient population. In this pilot study we will assess fasting and postprandial lipid metabolism of ovarian cancer patients before, during, and after treatment via indirect calorimetry.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10 (estimated)
- First submitted
- 30 Oct 2023
- Start date
- 22 Mar 2023
- Primary completion date
- 31 Mar 2027
- Lead sponsor
- University of Tennessee Graduate School of Medicine
- Diseases
- Ovarian cancer
- NCT number
- NCT06800105
What you commit to
- Study type: Observational
- Planned participants: 10
- From 22 Mar 2023 to the primary completion date, 31 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Illicit substance use (e.g. cocaine, methamphetamines, heroin, street drugs) - marijuana and CBD oil and related supplements will be considered on a case-by-case basis by the principal investigators
Other illness
- Circumstances and/or medical condition that would limit compliance with study requirements and protocol, as determined by the principal investigators
Other
- Pregnancy
- Inability to provide voluntary informed consent
- Inability to consume the pre-study visit meal/snack and/or the study visit meal due to strict dietary restrictions
Who the study is looking for
- Women
- Age \>18
- Presumed ovarian cancer diagnosis (i.e. those being clinically evaluated for suspicion of ovary cancer)
- Planned treatment course for ovarian cancer involving cytoreductive surgery followed by chemotherapy
- Availability to commit to attending all study visits
- Internet access and consistent access to phone/email/text communication
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Tennessee Graduate School of Medicine Coordinator of this site? Confirm its status | Knoxville | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.